Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Melanoma of the Skin (All Stages^), 2017-2021

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Recentaapc
State
 sort alphabetically by name ascending
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count descending
Recent Trend
Recent 5-Year Trend in Incidence Rates
(95% Confidence Interval)
 sort by trend ascending
US (SEER+NPCR) 1 22.7 (22.6, 22.8) N/A 86,630 stable stable trend -0.4 (-2.5, 1.5)
North Dakota 6 26.3 (24.7, 28.0) 16 (9, 24) 218 rising rising trend 10.1 (4.8, 15.0)
South Dakota 6 28.8 (27.3, 30.4) 8 (6, 15) 297 rising rising trend 4.2 (3.3, 5.2)
Iowa 7 31.4 (30.6, 32.2) 5 (4, 7) 1,170 rising rising trend 3.4 (3.2, 3.7)
Illinois 7 23.0 (22.6, 23.4) 27 (24, 31) 3,427 rising rising trend 3.2 (2.7, 3.6)
Texas 7 14.9 (14.7, 15.2) 48 (48, 49) 4,331 rising rising trend 3.0 (1.1, 6.6)
Ohio 6 25.8 (25.4, 26.1) 18 (15, 20) 3,682 rising rising trend 2.7 (2.1, 3.3)
Kentucky 7 28.2 (27.5, 28.9) 10 (8, 13) 1,487 rising rising trend 2.1 (1.7, 2.4)
Idaho 7 30.9 (29.8, 32.0) 6 (4, 8) 629 rising rising trend 2.0 (1.5, 2.6)
Alaska 6 14.8 (13.6, 16.2) 49 (47, 49) 110 rising rising trend 1.9 (0.6, 3.6)
Hawaii 7 23.8 (22.8, 24.8) 24 (20, 31) 450 stable stable trend 1.9 (-5.9, 2.9)
West Virginia 6 23.4 (22.5, 24.4) 26 (21, 31) 555 rising rising trend 1.9 (1.3, 2.5)
North Carolina 6 26.9 (26.4, 27.3) 14 (11, 17) 3,297 rising rising trend 1.8 (0.7, 2.5)
Wyoming 6 25.2 (23.5, 27.0) 20 (12, 29) 174 rising rising trend 1.8 (0.3, 3.5)
District of Columbia 6 10.0 (9.0, 11.2) 50 (50, 50) 68 rising rising trend 1.6 (0.1, 3.2)
Vermont 6 35.1 (33.2, 37.0) 3 (2, 3) 299 rising rising trend 1.5 (0.3, 2.8)
Maine 6 26.9 (25.8, 28.0) 13 (9, 20) 506 rising rising trend 1.4 (0.8, 2.1)
Maryland 6 24.5 (24.0, 25.0) 22 (19, 25) 1,791 rising rising trend 1.4 (0.7, 2.2)
California 7 22.7 (22.5, 23.0) 28 (26, 31) 10,029 rising rising trend 1.3 (1.0, 1.6)
Minnesota 6 37.3 (36.6, 38.0) 2 (2, 3) 2,447 stable stable trend 1.3 (-0.1, 2.3)
Utah 7 41.4 (40.3, 42.5) 1 (1, 1) 1,187 stable stable trend 1.2 (-1.0, 2.5)
Arizona 6 31.4 (30.9, 32.0) 4 (4, 7) 2,768 stable stable trend 1.1 (-1.0, 3.6)
Mississippi 6 19.3 (18.6, 20.0) 41 (38, 44) 656 stable stable trend 1.1 (-1.4, 1.9)
Nebraska 6 28.7 (27.7, 29.8) 9 (7, 13) 622 stable stable trend 1.0 (-1.9, 3.0)
Wisconsin 6 24.3 (23.7, 24.8) 23 (20, 26) 1,735 stable stable trend 1.0 (-1.0, 2.2)
Missouri 6 19.3 (18.8, 19.7) 42 (40, 43) 1,402 rising rising trend 0.8 (0.3, 1.3)
Michigan 6 20.4 (20.0, 20.8) 38 (34, 40) 2,496 rising rising trend 0.7 (0.1, 1.2)
Nevada 6 22.7 (22.0, 23.5) 29 (24, 32) 815 stable stable trend 0.7 (-3.9, 6.7)
Virginia 6 21.1 (20.7, 21.5) 34 (32, 37) 2,125 stable stable trend 0.7 (-0.5, 1.9)
Louisiana 7 18.2 (17.6, 18.7) 44 (42, 46) 958 stable stable trend 0.4 (-2.9, 2.6)
New Hampshire 6 29.9 (28.7, 31.1) 7 (4, 10) 551 stable stable trend 0.4 (-0.8, 1.6)
New York 7 17.4 (17.2, 17.7) 46 (45, 47) 4,276 stable stable trend 0.4 (-0.3, 0.9)
Alabama 6 21.3 (20.7, 21.8) 33 (31, 37) 1,273 stable stable trend 0.3 (-1.5, 1.4)
Washington 5 25.6 (25.1, 26.1) 19 (15, 21) 2,247 stable stable trend 0.1 (-1.4, 0.5)
Colorado 6 21.4 (20.9, 21.9) 32 (31, 36) 1,345 stable stable trend -0.2 (-2.4, 0.4)
New Jersey 7 20.7 (20.3, 21.1) 36 (33, 40) 2,357 stable stable trend -0.2 (-2.2, 0.9)
Tennessee 6 20.4 (19.9, 20.9) 37 (34, 40) 1,662 stable stable trend -0.2 (-1.6, 0.8)
New Mexico 7 17.1 (16.3, 17.8) 47 (44, 48) 451 stable stable trend -0.6 (-3.2, 0.2)
Florida 6 26.0 (25.7, 26.2) 17 (14, 20) 7,807 stable stable trend -0.8 (-3.5, 0.5)
Georgia 7 25.0 (24.6, 25.5) 21 (18, 23) 2,901 stable stable trend -1.8 (-5.8, 0.1)
Connecticut 7 18.5 (18.0, 19.1) 43 (41, 45) 852 falling falling trend -1.9 (-2.7, -1.3)
Kansas 6 27.6 (26.7, 28.4) 12 (8, 16) 915 stable stable trend -2.1 (-6.2, 1.9)
South Carolina 6 22.7 (22.1, 23.2) 30 (25, 31) 1,433 stable stable trend -2.4 (-7.1, 0.3)
Oklahoma 6 21.0 (20.3, 21.6) 35 (32, 40) 939 stable stable trend -2.7 (-8.3, 0.2)
Arkansas 6 22.4 (21.6, 23.1) 31 (25, 33) 797 stable stable trend -3.0 (-7.9, 3.0)
Montana 6 27.9 (26.6, 29.2) 11 (7, 16) 376 falling falling trend -3.6 (-7.5, -0.4)
Oregon 6 23.5 (22.9, 24.1) 25 (22, 30) 1,223 falling falling trend -4.2 (-8.2, -1.8)
Puerto Rico 6 3.3 (3.1, 3.6) N/A 132 stable stable trend -4.2 (-27.1, 26.0)
Pennsylvania 6 20.2 (19.9, 20.5) 39 (36, 41) 3,368 falling falling trend -4.6 (-6.3, -3.2)
Rhode Island 6 19.8 (18.7, 20.9) 40 (32, 44) 274 falling falling trend -4.7 (-11.0, -2.2)
Delaware 6 26.7 (25.4, 28.0) 15 (9, 21) 349 falling falling trend -8.5 (-12.7, -4.9)
Massachusetts 7 17.7 (17.3, 18.1) 45 (43, 47) 1,528 falling falling trend -14.7 (-20.6, -7.7)
Indiana 6
data not available
N/A
data not available
data not available
data not available
Notes:
Created by statecancerprofiles.cancer.gov on 10/06/2024 9:12 pm.

State Cancer Registries may provide more current or more local data.

Data cannot be shown for the following areas. For more information on what areas are suppressed or not available, please refer to the table.
Indiana

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.
Rates and trends are computed using different standards for malignancy. For more information see malignant.html.

^ All Stages refers to any stage in the Surveillance, Epidemiology, and End Results (SEER) Summary/Historic Combined Summary Stage (2004+).
⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

Data not available for this combination of data selections.
Source: SEER and NPCR data. For more specific information please see the table.

Data for the United States does not include data from Indiana.
Data for the United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top